Sumitomo Life Insurance Co. boosted its position in shares of Morgan Stanley (NYSE:MS – Free Report) by 34.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 22,416 shares of the financial services provider’s stock after purchasing an additional 5,780 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in Morgan Stanley were worth $2,818,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. DGS Capital Management LLC grew its stake in Morgan Stanley by 1.8% in the 4th quarter. DGS Capital Management LLC now owns 4,408 shares of the financial services provider’s stock valued at $554,000 after acquiring an additional 77 shares during the last quarter. Perfromance Wealth Partners LLC grew its position in shares of Morgan Stanley by 2.7% in the fourth quarter. Perfromance Wealth Partners LLC now owns 3,004 shares of the financial services provider’s stock valued at $378,000 after purchasing an additional 78 shares during the last quarter. Sivia Capital Partners LLC increased its stake in shares of Morgan Stanley by 3.3% during the 4th quarter. Sivia Capital Partners LLC now owns 2,748 shares of the financial services provider’s stock worth $346,000 after purchasing an additional 87 shares in the last quarter. Cardinal Point Capital Management ULC raised its position in shares of Morgan Stanley by 3.5% during the 4th quarter. Cardinal Point Capital Management ULC now owns 2,697 shares of the financial services provider’s stock worth $339,000 after purchasing an additional 90 shares during the last quarter. Finally, Mason & Associates Inc raised its position in shares of Morgan Stanley by 2.9% during the 4th quarter. Mason & Associates Inc now owns 3,177 shares of the financial services provider’s stock worth $399,000 after purchasing an additional 90 shares during the last quarter. Institutional investors and hedge funds own 84.19% of the company’s stock.
Morgan Stanley Stock Performance
NYSE MS opened at $138.49 on Wednesday. The company has a debt-to-equity ratio of 3.14, a current ratio of 0.80 and a quick ratio of 0.80. Morgan Stanley has a 1-year low of $83.09 and a 1-year high of $139.04. The firm has a market capitalization of $223.11 billion, a P/E ratio of 17.44, a P/E/G ratio of 1.20 and a beta of 1.36. The business’s 50-day simple moving average is $129.54 and its 200-day simple moving average is $115.26.
Morgan Stanley Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 31st will be given a $0.925 dividend. This represents a $3.70 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend is Friday, January 31st. Morgan Stanley’s dividend payout ratio (DPR) is presently 46.60%.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on MS shares. Hsbc Global Res cut Morgan Stanley from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th. The Goldman Sachs Group boosted their target price on shares of Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Bank of America raised their price target on shares of Morgan Stanley from $146.00 to $153.00 and gave the stock a “buy” rating in a research note on Friday, January 17th. JPMorgan Chase & Co. boosted their price objective on shares of Morgan Stanley from $104.00 to $108.00 and gave the company a “neutral” rating in a research report on Monday, January 13th. Finally, Citigroup raised their target price on shares of Morgan Stanley from $105.00 to $135.00 and gave the stock a “neutral” rating in a research report on Monday, November 25th. Eleven investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $131.27.
Check Out Our Latest Research Report on MS
Insiders Place Their Bets
In other news, CFO Raja Akram sold 17,500 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $136.01, for a total transaction of $2,380,175.00. Following the transaction, the chief financial officer now directly owns 81,440 shares of the company’s stock, valued at approximately $11,076,654.40. The trade was a 17.69 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Eric F. Grossman sold 13,097 shares of the business’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $136.20, for a total transaction of $1,783,811.40. Following the completion of the transaction, the insider now owns 197,444 shares in the company, valued at $26,891,872.80. This represents a 6.22 % decrease in their position. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by insiders.
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Read More
- Five stocks we like better than Morgan Stanley
- Upcoming IPO Stock Lockup Period, Explained
- Oklo’s Fuel Partnership Strengthens Bullish Case for Stock
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- SLB: Pioneering the Shift from Oil Services to Tech Solutions
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Apple Swings to Outperformer: Is It a Buy Ahead of Earnings?
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.